A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats

Veterinary Journal

Volumn 180, Issue 2, 2009, Pages 236-245

  Leemans, Jérôme ^a   Kirschvink, Nathalie ^b   Bernaerts, Frédérique ^a   Clercx, Cécile ^a   Cambier, Carole ^a   Gustin, Pascal ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Faculty of Sciences   (Belgium)

Author keywords

Barometric whole body plethysmography; Bronchial responsiveness; Feline; Inhaled bronchodilators

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CAT; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FECES INCONTINENCE; FEMALE; HYPERSALIVATION; MALE; METERED DOSE INHALER; NEBULIZER; NONHUMAN; PATIENT COMPLIANCE; PILOT STUDY; PRIMARY PREVENTION; PROTECTION; VOMITING;

ADMINISTRATION, INHALATION; ALBUTEROL; ANIMALS; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CATS; FEMALE; IPRATROPIUM; MALE; METERED DOSE INHALERS; PILOT PROJECTS; PLETHYSMOGRAPHY, WHOLE BODY;

FELIDAE;

EID: 61849102955     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.11.008     Document Type: Article

References (57)

1. Adler A., Cieslewicz G., and Irvin C.G. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. Journal of Applied Physiology 97 (2004) 286-292
2. Bates J., Irvin C., Brusasco V., Drazen J., Fredberg J., Loring S., Eidelman D., Ludwig M., Macklem P., Martin J., Milic-Emili J., Hantos Z., Hyatt R., Lai-Fook S., Leff A., Solway J., Lutchen K., Suki B., Mitzner W., Pare P., Pride N., and Sly P. The use and misuse of Penh in animal models of lung disease. American Journal of Respiratory Cell and Molecular Biology 31 (2004) 373-374
3. Bay J.D., and Johnson L.R. Feline bronchial disease/asthma. In: King L.G. (Ed). Respiratory disease in dogs and cats (2004), Saunders, St. Louis, Missouri, USA 388-396
4. Bellary S., and Barnett A.H. Inhaled insulin: new technology, new possibilities. International Journal of Clinical Practice 60 (2006) 728-734
5. Blaber L.C., and Fryer A.D. The response of cat airways to histamine in vivo and in vitro. British Journal of Pharmacology 84 (1985) 309-316
6. Bongrani S., Schiantarelli P., Papotti M., and Folco G.C. Evidence of overadditive interaction between fenoterol and ipratropium bromide in the counteraction of cholinomimetic-induced tracheobronchial contractions. Arzneimittelforschung 31 (1981) 970-973
7. Boothe D.M. Drugs affecting the respiratory system. In: King L.G. (Ed). Respiratory disease in dogs and cats (2004), Saunders, St. Louis, Missouri, USA 229-252
8. Buhl R., and Farmer S.G. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma. Proceedings of the American Thoracic Society 1 (2004) 136-142
9. Chand N. Reactivity of isolated trachea, bronchus and lung strip of cats of carbachol, 5-hydroxytryptamine and histamine: evidence for the existence of methysergide-sensitive receptors. British Journal of Pharmacology 73 (1981) 853-857
10. Cushley M.J., and Holgate S.T. Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax 40 (1985) 176-179
11. Diamond L., and O'Donnell M. A comparative study of two parasympatholytic bronchodilator agents: ipratropium bromide and diphemanil methylsulfate. Journal of Pharmacology and Experimental Therapeutics 216 (1981) 1-5
12. Diot P., Mallet J.P., and Lemarie E. Aerosols: a re-emerging treatment. Revue de Pneumologie Clinique 54 (1998) 125-134
13. Dolovich M.B., Ahrens R.C., Hess D.R., Anderson P., Dhand R., Rau J.L., Smaldone G.C., and Guyatt G. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127 (2005) 335-371
14. Dowling P.M. Options for treating feline asthma. Veterinary Medicine (2001) 353-356
15. Dutta E.J., and Li J.T. Beta-agonists. Medical Clinics of North America 86 (2002) 991-1008
16. Dye J.A., Mc Kiernan B.C., Jones S.D., Neff-Davis C.A., and Koritz G.D. Sustained-release theophylline pharmacokinetics in the cat. Journal of Veterinary Pharmacology and Therapeutics 12 (1989) 133-140
17. Dye J.A., McKiernan B.C., Rozanski E.A., Hoffman W.E., Losonsky J.M., Homco L.D., Weisiger R.M., and Kakoma I. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. Journal of Veterinary Internal Medicine 10 (1996) 385-400
18. Elwood R.K., and Abboud R.T. The short-term bronchodilator effects of fenoterol and ipratropium in asthma. Journal of Allergy and Clinical Immunology 69 (1982) 467-473
19. Fernandes L.B., Fryer A.D., and Hirshman C.A. M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. Journal of Pharmacology and Experimental Therapeutics 262 (1992) 119-126
20. Francis P.W., Krastins I.R., and Levison H. Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm. Pediatrics 66 (1980) 103-108
21. Geller D.E. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respiratory Care 50 (2005) 1313-1321
22. Gross N.J. Anticholinergic agents in asthma and COPD. European Journal of Pharmacology 533 (2006) 36-39
23. Halloy D., Kirschvink N., Vincke G., Hamoir J.N., Delvaux F., and Gustin P. Whole body barometric plethysmography: a screening method to investigate airway reactivity and acute lung injuries in freely moving pigs. The Veterinary Journal 168 (2004) 276-284
24. Hamelmann E., Schwarze J., Takeda A., Oshiba G., Larsen G.L., Irvin G., and Gelfand E.W. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. American Journal of Respiratory and Critical Care Medicine 156 (1997) 766-775
25. Hirt, R., Dederichs, D., 2001. Quantification of bronchoconstriction and response to nebulized beta2-bronchodilators in spontaneously occurring feline asthma. In: Proceedings of the 7th Annual Meeting of the Federation of European Companion Animal Veterinary Associations, Berlin, Germany, pp. 41-42.
26. Hirt R.A., Dederichs D., Boehler A., and Hoffman A.M. Relationship of age, sex, body weight, and hematologic and respiratory variables with airway reactivity in adult cats. American Journal of Veterinary Research 64 (2003) 26-31
27. Hirt R.A., and Vondrakova K. Adenosine 5′-monophosphate aerosol challenge does not provoke airflow limitation in healthy cats. Proceedings of the 15th Congress of the European College of Veterinary Internal Medicine - Companion Animals (2005), Glasgow, Scotland 221
28. Hochhaus G. New developments in corticosteroids. Proceedings of the American Thoracic Society 1 (2004) 269-274
29. Hoffman A.M., Dhupa N., and Cimetti L. Airway reactivity measured by barometric whole-body plethysmography in healthy cats. American Journal of Veterinary Research 60 (1999) 1487-1492
30. Jarjour N.N., Wilson S.J., Koenig S.M., Laviolette M., Moore W.C., Davis W.B., Doherty D.E., Hamid Q., Israel E., Kavuru M.S., Ramsdell J.W., Tashkin D.P., Reilly D.S., Yancey S.W., Edwards L.D., Stauffer J.L., Dorinsky P.M., and Djukanovic R. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. Journal of Allergy and Clinical Immunology 118 (2006) 44-52
31. Kirschvink N., Hirt R.A., Delvaux F., Vincke G., Clercx C., and Gustin P. Bronchoprotective effects of inhaled salmeterol, fenoterol and oxitropium in healthy cats. Journal of Veterinary Internal Medicine 17 (2003) 747
32. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., and Gustin P. Bronchodilators in bronchoscopy-induced airflow limitation in allergen-sensitized cats. Journal of Veterinary Internal Medicine 19 (2005) 161-167
33. Kirschvink N., Vincke G., Onclinx C., Peck M., and Gustin P. Comparison between pulmonary resistance and Penh in anaesthetised rats with tracheal diameter reduction and after carbachol inhalation. Journal of Pharmacological and Toxicological Methods 51 (2005) 123-128
34. Kirschvink N., Leemans J., Delvaux F., Snaps F., Jaspart S., Evrard B., Delattre L., Cambier C., Clercx C., and Gustin P. Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. Journal of Feline Medicine and Surgery 8 (2006) 45-54
35. Kirschvink N., Leemans J., Delvaux F., Snaps F., Marlin D., Sparkes A., Clercx C., and Gustin P. Non-invasive assessment of growth, gender and time of day related changes of respiratory pattern in healthy cats by use of barometric whole body plethysmography. The Veterinary Journal 172 (2006) 446-454
36. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., and Gustin P. Non-invasive assessment of airway responsiveness in healthy and allergen-sensitised cats by use of barometric whole body plethysmography. The Veterinary Journal 173 (2007) 343-352
37. Li X., Ward C., Thien F., Bish R., Bamford T., Bao X., Bailey M., Wilson J.W., and Haydn W.E. An antiinflammatory effect of salmeterol, a long-acting beta (2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. American Journal of Respiratory and Critical Care Medicine 160 (1999) 1493-1499
38. Lulich K.M., Mitchell H.W., and Sparrow M.P. The cat lung strip as an in vitro preparation of peripheral airways: a comparison of beta-adrenoceptor agonists, autacoids and anaphylactic challenge on the lung strip and trachea. British Journal of Pharmacology 58 (1976) 71-79
39. McKiernan B.C., Koritz G.D., Davis L.E., Neff-Davis C.A., and Pheris D.R. Pharmacokinetic studies of theophylline in cats. Journal of Veterinary Pharmacology and Therapeutics 6 (1983) 99-104
40. McKiernan B.C., Dye J.A., and Rozanski E.A. Tidal breathing flow-volume loops in healthy and bronchitic cats. Journal of Veterinary Internal Medicine 7 (1993) 388-393
41. Naline E., Zhang Y., Qian Y., Mairon N., Anderson G.P., Grandordy B., and Advenier C. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. European Respiratory Journal 7 (1994) 914-920
42. O'Riordan T.G. Aerosol delivery devices and obstructive airway disease. Expert Review of Medical Devices 2 (2005) 197-203
43. Oberklaid F., Mellis C.M., Souef P.N., Geelhoed G.C., and Maccarrone A.L. A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children. Medical Journal of Australia 158 (1993) 751-753
44. Padrid P.A., Mitchell R.W., Ndukwu I.M., Spaethe S., Shiue P., Cozzi P., Leff A.R., and Shiou P. Cyproheptadine-induced attenuation of type-I immediate-hypersensitivity reactions of airway smooth muscle from immune-sensitized cats. American Journal of Veterinary Research 56 (1995) 109-115
45. Padrid P.A. Feline asthma: diagnosis and treatment. Veterinary Clinics of North America: Small Animal Practice 30 (2000) 1279-1294
46. Palmqvist M., Ibsen T., Mellen A., and Lotvall J. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. American Journal of Respiratory and Critical Care Medicine 160 (1999) 244-249
47. Parker A.L. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction. Journal of Asthma 41 (2004) 671-677
48. Reinero C.R., Decile K.C., Byerly J.R., Berghaus R.D., Walby W.E., Berghaus L.J., Hyde D.M., Schelegle E.S., and Gershwin L.J. Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. American Journal of Veterinary Research 66 (2005) 1121-1127
49. Reinero C.R., Brownlee L., Decile K.C., Seguin B., Berghaus R.D., Nelson R.W., and Gershwin L.J. Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. Journal of Veterinary Internal Medicine 20 (2006) 57-64
50. Rozanski E.A., and Hoffman A.M. Lung function and inhaled albuterol in cats with asthma. Journal of Veterinary Internal Medicine 13 (1999) 259
51. Schuh S., Johnson D.W., Callahan S., Canny G., and Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. The Journal of Pediatrics 126 (1995) 639-645
52. Schulman R.L., Crochik S.S., Kneller S.K., McKiernan B.C., Schaeffer D.J., and Marks S.L. Investigation of pulmonary deposition of a nebulized radiopharmaceutical agent in awake cats. American Journal of Veterinary Research 65 (2004) 806-809
53. Sharma A., and Madaan A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian Journal of Pediatrics 71 (2004) 121-124
54. Tattersfield A.E. Clinical pharmacology of long-acting beta-receptor agonists. Life Sciences 52 (1993) 2161-2169
55. Talavera, J., Bernaerts, F., Kirschvink, N., Gustin, P., Clercx C., 2005. Impact of nebulizer on airway reactivity measurements in healthy dogs. In: Proceedings of the 23rd Annual Forum of the American College of Veterinary Internal Medicine, Baltimore, USA, pp. 180.
56. van den Hoven R. A jack-in-the-box of respiratory research: is the technique of barometric whole body plethysmography a disappointing surprise?. The Veterinary Journal 173 (2007) 250-251
57. Zhang Y., Molimard M., and Advenier C. Influence of methoctramine on the acetylcholine-isoprenaline functional antagonism in the guinea pig isolated trachea. Fundamental and Clinical Pharmacology 10 (1996) 436-441